Eli Lilly CEO David Ricks (L) and Sanofi CEO Paul Hudson at a Senate hearing entitled 'The Need to Make Insulin Affordable for All Americans' (Al Drago/Bloomberg via Getty Images)
May 10, 2023 03:52 PM EDT
Pharma

In­sulin prices in the Sen­ate hot seat: PBM and phar­ma fin­ger-point­ing con­tin­ues as land­scape shifts

Zachary Brennan

Senior Editor

The CEOs from Eli Lil­ly, Sanofi and No­vo Nordisk and ex­ec­u­tives from top phar­ma­cy ben­e­fit man­agers were in the hot seat on Capi­tol Hill on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times